| Health / Medical Topics |
Serine/Threonine Kinase Inhibitor CBP501
A peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine/threonine kinases, including MAPKAP-K2, C-Tak1, and CHK1, that phosphorylate serine 216 of the dual-specific phosphatase Cdc25C (cell division checkpoint 25 C); disruption of Cdc25C activity results in the inhibition of Cdc25C dephosphorylation of the mitotic cyclin-dependent kinase complex Cdc2/cyclin B, preventing entry into the mitotic phase of the cell cycle. (NCI Thesaurus)
YOU MAY ALSO LIKE
Any substance that inhibits serine/threonine protein kinase, an enzyme that phosphorylates the hydroxyl group of serine or threonine on various proteins in…
Serine/arginine-rich splicing factor 3 (164 aa, ~19 kDa) is encoded by the human SRSF3 gene. This protein plays a role in mRNA…
Serine/arginine-rich splicing factor 2 (221 aa, ~25 kDa) is encoded by the human SRSF2 gene. This protein plays a role in the…
Serine-rich coiled-coil domain-containing protein 1 (900 aa, ~100 kDa) is encoded by the human CCSER1 gene. This protein may be involved in…
Serine-protein kinase ATM (3056 aa, ~351 kDa) is encoded by the human ATM gene. This protein is involved in DNA damage-induced protein…
A protein that plays a role in the inhibition of serine proteinases.
